These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35674352)
1. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth. Byrne SC; Hammer MM AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352 [No Abstract] [Full Text] [Related]
2. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT. Hammer MM; Byrne SC AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524 [No Abstract] [Full Text] [Related]
3. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice. Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453 [No Abstract] [Full Text] [Related]
4. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data. Hammer MM; Hunsaker AR AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912 [No Abstract] [Full Text] [Related]
5. Improved Interobserver Agreement on Lung-RADS Classification of Solid Nodules Using Semiautomated CT Volumetry. Gierada DS; Rydzak CE; Zei M; Rhea L Radiology; 2020 Dec; 297(3):675-684. PubMed ID: 32930652 [TBL] [Abstract][Full Text] [Related]
6. Rate of benign nodule resection in a lung cancer screening program. El Alam R; Byrne SC; Hammer MM Clin Imaging; 2023 Dec; 104():109984. PubMed ID: 37832324 [TBL] [Abstract][Full Text] [Related]
7. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the Patient With a Pulmonary Nodule: A Review. Mazzone PJ; Lam L JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882 [TBL] [Abstract][Full Text] [Related]
9. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines. van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773 [TBL] [Abstract][Full Text] [Related]
10. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations. Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766 [TBL] [Abstract][Full Text] [Related]
11. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program. Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610 [TBL] [Abstract][Full Text] [Related]
12. Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial. Robbins HA; Katki HA; Cheung LC; Landy R; Berg CD J Thorac Oncol; 2019 Sep; 14(9):1662-1665. PubMed ID: 31125735 [TBL] [Abstract][Full Text] [Related]
13. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275 [TBL] [Abstract][Full Text] [Related]
14. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry. Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105 [TBL] [Abstract][Full Text] [Related]
15. Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? Chung K; Jacobs C; Scholten ET; Goo JM; Prosch H; Sverzellati N; Ciompi F; Mets OM; Gerke PK; Prokop M; van Ginneken B; Schaefer-Prokop CM Radiology; 2017 Jul; 284(1):264-271. PubMed ID: 28339311 [TBL] [Abstract][Full Text] [Related]
16. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial. Hammer MM; Palazzo LL; Kong CY; Hunsaker AR Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256 [TBL] [Abstract][Full Text] [Related]
17. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial. Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151 [TBL] [Abstract][Full Text] [Related]
18. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination. Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760 [TBL] [Abstract][Full Text] [Related]
19. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial. Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631 [TBL] [Abstract][Full Text] [Related]
20. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules. Sundaram V; Gould MK; Nair VS Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]